F Ripamonti
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Microbiology top 10%
- Antimicrobial Peptides and Activities
Papers in
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 11
-
- RNA and protein synthesis mechanisms 2
- Co-authors
- Beth P. Goldstein (11 shared papers)Maurizio Denaro (6 shared papers)M Berti (7 shared papers)Pietro Ferrari (5 shared papers)Enrico Selva (3 shared papers)Romeo Ciabatti (6 shared papers)Luciano Gastaldo (2 shared papers)Paolo Landini (3 shared papers)
- Journals
- The Journal of Antibiotics (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Current Microbiology (1 paper)Journal of Medicinal Chemistry (1 paper)Biochemical Journal (1 paper)
- Partner nations
- ItalyUnited KingdomRussia
In The Last Decade
F Ripamonti
18 papers receiving 483 citations
Peers
Comparison fields: 5 of 54
- Pharmacology 251
- Microbiology 59
- Toxicology 29
- Organic Chemistry 208
- Molecular Medicine 27
Countries citing papers authored by F Ripamonti
This map shows the geographic impact of F Ripamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Ripamonti more than expected).
Fields of papers citing papers by F Ripamonti
This network shows the impact of papers produced by F Ripamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Ripamonti. The network helps show where F Ripamonti may publish in the future.
Co-authors
The 25 scholars most cited alongside F Ripamonti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 155 | |
| 2 | 1987 | 92 | |
| 3 | 1997 | 54 | |
| 4 | 1994 | 41 | |
| 5 | 1995 | 34 | |
| 6 | 1999 | 33 | |
| 7 | 1995 | 30 | |
| 8 | 1992 | 29 | |
| 9 | 1993 | 18 | |
| 10 | 1997 | 11 | |
| 11 | Synthesis and antimicrobial activities of 4-purpuromycin derivatives. | 1996 | 8 |
| 12 | 1992 | 7 | |
| 13 | Chemical modifications of the antibiotic purpuromycin. | 1993 | 7 |
| 14 | 1995 | 6 | |
| 15 | 1996 | 6 | |
| 16 | 1979 | 4 | |
| 17 | 1983 | 4 | |
| 18 | SYNTHESIS AND ACTIVITY STUDIES ON 3-(CARBOXYALKYLTHIO)RIFAMYCIN S DERIVATIVES | 1997 | 2 |
About F Ripamonti
F Ripamonti is a scholar working on Pharmacology, Molecular Biology, Organic Chemistry, Infectious Diseases and Toxicology, having authored 18 papers that have together received 541 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Bioactive Compounds and Antitumor Agents (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Antifungal resistance and susceptibility (2 papers), Antimicrobial Peptides and Activities (2 papers), Carbohydrate Chemistry and Synthesis (2 papers), RNA and protein synthesis mechanisms (2 papers) and Infectious Diseases and Mycology (2 papers). The work is most often cited by research in Pharmacology (251 citations), Microbiology (59 citations), Toxicology (29 citations), Organic Chemistry (208 citations) and Molecular Medicine (27 citations). F Ripamonti has collaborated with scholars based in Italy, United Kingdom and Russia. Frequent co-authors include Beth P. Goldstein, Maurizio Denaro, M Berti, Pietro Ferrari, Enrico Selva, Romeo Ciabatti, Luciano Gastaldo, Paolo Landini, G. S. Saddler and Lucio Montanaro. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Current Microbiology, Journal of Medicinal Chemistry and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.